Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2025-12-25 @ 2:54 AM
NCT ID:
NCT03946033
Eligibility Criteria:
Inclusion Criteria:
* Cytologically/histologically proven colon adenocarcinoma
* non-metastatic cancer
* Stage II or III adenocarcinoma
* Surgical resection of primitive tumor within 6 weeks of multidisciplinary meeting
* No macroscopic or microscopic proof of residual disease during surgery (R0 margins)
* Available surgical material: FFPE tumor samples
* Post-operative adjuvant chemotherapy considered during multidisciplinary meeting
* Age ≥18 years
* Eastern Cooperative Oncology Group (ECOG) performance status ≤2
* Patient having signed a written informed consent prior to any trial specific procedures
* Patient affiliated to the social security system or equivalent
Exclusion Criteria:
* Other invasive cancer within 5 years of the colon cancer diagnosis, except for adequately treated basal cell carcinoma or squamous cell skin carcinoma or in sity cervical carcinoma
* Patients for which adjuvant chemotherapy is contra-indicated
* Any previous systemic or loco regional anticancer therapy for the studied colon cancer (e.g. neoadjuvant therapy)
* Patient enrolled or planned to be enrolled in another clinical trial that may influence the therapeutic decision
* Any psychological, social or geographical issue that may hinder the patient's understanding of the study or the study conduct
* Person deprived of liberty or under the authority of a legal guardian
* Person unable to understand the study or to comply with the protocol procedures
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03946033
Study Brief:
Protocol Section:
NCT03946033